Asthma is a chronic condition that affects millions of people around the world. It can range from mild to severe, and for those with severe asthma, the symptoms can be debilitating. Fortunately, there is a revolutionary new treatment option for those with severe asthma: Dupixent®. Dupixent® is a biologic medication that works by blocking two proteins that contribute to the inflammation and airway constriction associated with severe asthma. This innovative medication has the potential to significantly improve the quality of life for those living with severe asthma. In this article, we will discuss the benefits of Dupixent® and how it can help unlock a better quality of life for those with severe asthma.
Dupixent® is a biologic medication that works by blocking two proteins, interleukin (IL)-4 and IL-13, which are involved in the inflammation and airway constriction associated with severe asthma. It is administered through an injection every two weeks. Dupixent® is the only biologic medication approved by the FDA for the treatment of severe asthma in adults and adolescents 12 years and older.
Dupixent® has been shown to significantly reduce the symptoms of severe asthma and improve quality of life in those who take it. In clinical trials, patients taking Dupixent® showed a significant reduction in the number of times they experienced an asthma attack, as well as a decrease in their need for rescue inhalers. Patients also reported improved lung function and an increase in their overall quality of life.
Dupixent® is approved for the treatment of severe asthma in adults and adolescents 12 years and older. It is important to note, however, that Dupixent® is not recommended for those with mild to moderate asthma, as it is not effective in treating this form of the condition.
As with any medication, there are potential side effects associated with Dupixent®. The most common side effects include injection site reactions, upper respiratory infections, and headache. While these side effects are generally mild and can be managed with over-the-counter medications, it is important to discuss any potential side effects with your doctor before starting Dupixent®.
Dupixent® is a revolutionary new treatment option for those with severe asthma. It has been shown to significantly reduce the symptoms of severe asthma and improve quality of life in those who take it. While it is important to discuss any potential side effects with your doctor before starting Dupixent®, the potential benefits of this innovative medication can be life-changing for those living with severe asthma.
1.
Lesser-known lobular breast cancer on the rise in U.S. women
2.
Study finds that AI is better at forecasting the risk of developing cancer.
3.
Kate Middleton and Remission: Oncologists Weigh In
4.
According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.
5.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
1.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
2.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
3.
Tumor-Specific Fluorescent Peptide Navigation in Surgical Oncology
4.
Digital Blood Cell Morphology Libraries for Longitudinal Hematologic Monitoring
5.
The importance of understanding normal serum osmolality
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
5.
Best Practices in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation